NCT05699226View on ClinicalTrials.gov

Amplitude Titration to Improve ECT Clinical Outcomes

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions
DepressionECTCognitive Change
Interventions
DEVICE

Soterix Medical Incorporated 4x1 adapter

Device permits individualized amplitudes

DEVICE

Traditional ECT device

FDA approved ECT device with fixed amplitude.

Trial Locations (1)

87110

RECRUITING

University of New Mexico Health Science Center, Albuquerque

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of New Mexico

OTHER